Lewis R D, Marken B F, Smith S R
GlaxoSmithKline Consumer Healthcare, St. George's Avenue, Weybridge, Surrey, KT13 ODE, United Kingdom.
SADJ. 2001 Apr;56(4):178-81.
A chalk-based antimicrobial dentifrice was developed and has undergone in vitro testing to determine antimicrobial efficacy by kill-time studies, and in vivo clinical studies to determine anti-plaque build-up properties. The antimicrobial efficacy of the formulation is attributable to the following components; sodium lauryl sulphate, sodium monofluorophosphate, flavouring oils, triclosan, and low water activity. In vitro kill-time testing showed the dentifrice to have good activity against organisms associated with plaque, showing at least 99% reductions in the numbers of each organism. In vivo clinical results showed the dentifrice to protect against the build-up of plaque when compared to water alone. These results demonstrate that this dentifrice is effective in controlling plaque, and can thus be expected to promote good oral hygiene.
一种基于白垩的抗菌牙膏已研发出来,并通过杀菌时间研究进行了体外测试以确定抗菌效果,还通过体内临床研究来确定其抗牙菌斑形成的特性。该配方的抗菌效果归因于以下成分:月桂醇硫酸酯钠、单氟磷酸钠、调味油、三氯生和低水分活度。体外杀菌时间测试表明,该牙膏对与牙菌斑相关的微生物具有良好的活性,每种微生物数量至少减少99%。体内临床结果表明,与单独用水相比,该牙膏可防止牙菌斑形成。这些结果表明,这种牙膏在控制牙菌斑方面是有效的,因此有望促进良好的口腔卫生。